Abstract:Objectives Diabetes-induced impairment of collateral formation in ischaemic myocardium has been demonstrated both in experimental and clinical studies, which may contribute to unfavorableprognosis among diabetic individuals. However, the underlying mechanism remains to be defined. Endothelial cell (EC) is thought to be one of the important elements in the development and maturation of coronary collaterals. Since ERK5 is a novel regulator of angiogenesis and closely related with VEGF, in present study we aim to determine whether ERK5 exerts a causative effect on advanced glycation end products (AGEs)-induced impairment of angiogenic capacity in cardiac ECs under hypoxia condition, and to identify the down streamtarget molecule. Methods Cardiac ECs were isolated from left ventricle of Sprague-Dawley rats with a enzyme digestion procedure described in our previous publications. Cells were treated with or without AGEs and then exposed to hypoxia or normoxia. Proliferation, migration and tube-forming of endothelial cells were detected by MTT, Transwell and Matrigel assay respectively. Protein of interest were further validated using ELISA and Western-blot techniques. Results Hypoxia promoted proliferation, migration and tube-forming capacity in cardiac ECs, which was inhibited significantly by combined administration of AGEs. Incubation with AGEs induced decrease of VEGF secretion and increase of ERK5 phosphorylation after hypoxia stimulation. XMD8-92, a inhibitor of ERK5 phosphorylation, treatment caused elevation of VEGF secretion, and counteracted AGEs-induced impairment of angiogenic capacity in cardiac ECs under hypoxia condition, which has a similar effect with supplementation of exogenous VEGF. Conclusions Our study demonstrated for the first time that hypoxia-induced enhancement of angiogenic capacity in cardiac ECs was inhibited in the presence of AGEs, which was related with downregulation of VEGF expression caused by ERK5 phosphorylation. Thus ERK5 may function as an important regulator in diabetes-induced impairment of angiogenesis and thereby exacerbated myocardial ischaemic injury through coordinately targeting VEGF in cardiac ECs. Intervention of ERK5 pathway mayrepresent an avenue for therapeutic exploitation to improve prognosis in diabetic individuals with coronary artery disease.

Synergistic Proliferation Induced by Insulin and Glycated Serum Albumin in Rat Vascular Smooth Muscle Cells.

Erk And Akt Signaling Pathways Are Involved In Advanced Glycation End Product-Induced Autophagy In Rat Vascular Smooth Muscle Cells

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

Sustained Release of Stromal Cell-Derived Factor-1α from Injectable Hydrogels in Combination with Endothelial Progenitor Cells Effectively Promotes Neovascularization in Ischemic Diabetic Rats

Advanced Glycation End Products Facilitate Proliferation and Reduce Early Apoptosis of Cardiac Microvascular Endothelial Cell Via PKCβ Signaling Pathway: Insight from Diabetic Cardiomyopathy

Simultaneous Increases in Proliferation and Apoptosis of Vascular Smooth Muscle Cells Accelerate Diabetic Mouse Venous Atherosclerosis

Advanced glycation end products activate Smad signaling via TGF- -dependent and -independent mechanisms: implications for diabetic renal and vascular disease

Advanced Glycation End Products Induce Vascular Smooth Muscle Cell-Derived Foam Cell Formation and Transdifferentiate to a Macrophage-Like State.

We-P11:120 Role of Peroxisome Proliferators Activated Receptor-Gama in Mediating Proliferation of Rat Vascular Smooth Muscle Cells Induced by Advanced Glycation End Products

Advanced Glycation End Products Accelerate Rat Vascular Calcification Through RAGE/oxidative Stress.

RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation

Glycation of High-Density Lipoprotein Triggers Oxidative Stress and Promotes the Proliferation and Migration of Vascular Smooth Muscle Cells

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes.

Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.

Effect of pioglitazone on AGE-BSA induced proliferation and plasminogen activator inhibitor-1 mRNA expression of rat vascular smooth muscle cells

Abstract 195: Simvastatin Rescues Impaired Angiogenesis Potential of Cerebrovascular Endothelial Cells by AGEs : the Role of Autophagy

Sodium Tanshinone IIA Silate Inhibits High Glucose-Induced Vascular Smooth Muscle Cell Proliferation and Migration through Activation of AMP-Activated Protein Kinase

GW24-e3729 ERK5 Mediates Advanced Glycation End Products-Induced Impairment of Angiogenic Capacity in Cardiac Endothelial Cells under Hypoxia Condition Through Regulation of VEGF Expression

Selective Inhibition by Grape Seed Proanthocyanidin Extracts of Cell Adhesion Molecule Expression Induced by Advanced Glycation End Products in Endothelial Cells.

Effects of Sinapic Acid on Proliferation and Apoptosis of Rat Vascular Smooth Muscle Cells Induced by High Glucose

Glycated serum albumin stimulates expression of endothelial cell specific molecule-1 in human umbilical vein endothelial cells: Implication in diabetes mediated endothelial dysfunction